Skip to main content

Table 6 Summary of clinical studies in KAMRA

From: Presbyopic correction on the cornea

Study

n

Follow-Up

UDVA

UNVA

DCNVA

CDVA

CNVA

Retreat.

Reversal

Dexl AK et al. [41]

32

2Y

20/16

J3

---

---

---

---

---

Yılmaz et al. [39]

22

4Y

96%ā€‰>ā€‰20/25

96%ā€‰>ā€‰J2

---

5%ā€‰<ā€‰āˆ’2lns

---

---

18%

Dexl AK et al. [42]

24

1Y

20/16 100%ā€‰>ā€‰20/25

J2 92%ā€‰>ā€‰J3

---

4%ā€‰<ā€‰āˆ’2lns

8%ā€‰<ā€‰āˆ’2lns

0%

0%

Tomita M et al. [43]

64

6M

20/19 86%ā€‰>ā€‰20/25

J2 60%ā€‰>ā€‰J2

---

5%ā€‰<ā€‰āˆ’2lns

2%ā€‰<ā€‰āˆ’2lns

1%

---

Dexl et al. [44]

24

2Y

20/16

J4

---

4%ā€‰<ā€‰āˆ’2lns

---

0%

0%

Grand total

166

6M-4Y

20/17 93%ā€‰>ā€‰20/25

J3 73%ā€‰>ā€‰J2

---

5%ā€‰<ā€‰āˆ’2lns

5%ā€‰<ā€‰āˆ’2lns

1%

6%

  1. UDVA: uncorrected distance visual acuity, UNVA: uncorrected near visual acuity, n: number of patients in the study, DCNVA: distance-corrected near visual acuity, CDVA: corrected distance visual acuity, CNVA: corrected near visual acuity, Retreat.: retreatment rate, M: months, Y: year(s), J: Jaeger scale for near vision, lns: Snellen lines.